Ocular adnexal lymphoma – a retrospective study and review of the literature

1. Mugnaini EN, Ghosh N. Lymphoma. Prim Care 2016; 43: 661–75. doi: 10.1016/j.pop.2016.07.012 MugnainiEN GhoshN Lymphoma Prim Care 2016 43 661 75 10.1016/j.pop.2016.07.012 Open DOISearch in Google Scholar

2. Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin North Am 2008; 46: 175–98. doi: 10.1016/j.rcl.2008.03.005 MatasarMJ ZelenetzAD Overview of lymphoma diagnosis and management Radiol Clin North Am 2008 46 175 98 10.1016/j.rcl.2008.03.005 Open DOISearch in Google Scholar

3. Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai M. Orbital and adnexal involvement in systemic non-Hodgkin’s lymphoma. Cancer 1994; 73: 2395–99. doi: 10.1002/1097-0142(19940501)73:9<2395::AIDCNCR2820730924>3.0.CO;2-V BaireyO KremerI RakowskyE HadarH ShaklaiM Orbital and adnexal involvement in systemic non-Hodgkin’s lymphoma Cancer 1994 73 2395 99 10.1002/1097-0142(19940501)73:9<2395::AIDCNCR2820730924>3.0.CO;2-V Open DOISearch in Google Scholar

4. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol 2005; 49: 49–55. doi: 10.1007/s10384-004-0147-y OhtsukaK HashimotoM SuzukiY A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations Jpn J Ophthalmol 2005 49 49 55 10.1007/s10384-004-0147-y Open DOISearch in Google Scholar

5. Sjö LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol 2009; 87: 1–20. doi: 10.1111/j.1755-3768.2008.01478.x SjöLD Ophthalmic lymphoma: epidemiology and pathogenesis Acta Ophthalmol 2009 87 1 20 10.1111/j.1755-3768.2008.01478.x Open DOISearch in Google Scholar

6. Coupland SE, White VA, Rootman J, Damato B, Finger PT. A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med 2009; 133: 1262–67. doi: 10.5858/133.8.1262 CouplandSE WhiteVA RootmanJ DamatoB FingerPT A TNM-based clinical staging system of ocular adnexal lymphomas Arch Pathol Lab Med 2009 133 1262 67 10.5858/133.8.1262 Open DOISearch in Google Scholar

7. Bardenstein DS. Ocular adnexal lymphoma: classification, clinical disease, and molecular biology. Ophthalmol Clin North Am 2005; 18: 187–97. doi: 10.1016/j.ohc.2004.11.001 BardensteinDS Ocular adnexal lymphoma: classification, clinical disease, and molecular biology Ophthalmol Clin North Am 2005 18 187 97 10.1016/j.ohc.2004.11.001 Open DOISearch in Google Scholar

8. Coupland SE, Krause L, Delecluse HJ, Anagnostopoulos I, Foss HD, Hummel M, et al. Lymphoproliferative lesions of the ocular adnexa: Analysis of 112 cases. Ophthalmology 1998; 105: 1430–41. doi: 10.1016/S0161-6420(98)98024-1 CouplandSE KrauseL DelecluseHJ AnagnostopoulosI FossHD HummelM Lymphoproliferative lesions of the ocular adnexa: Analysis of 112 cases Ophthalmology 1998 105 1430 41 10.1016/S0161-6420(98)98024-1 Open DOISearch in Google Scholar

9. McKelvie PA, McNab A, Francis IC, Fox R, O’Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol 2001; 29: 387–93. doi: 10.1046/j.1442-9071.2001.d01-18.x McKelviePA McNabA FrancisIC FoxR O’DayJ Ocular adnexal lymphoproliferative disease: a series of 73 cases Clin Exp Ophthalmol 2001 29 387 93 10.1046/j.1442-9071.2001.d01-18.x Open DOISearch in Google Scholar

10. Bernardini FP, Bazzan M. Lymphoproliferative disease of the orbit. Curr Opin Ophthalmol 2007; 18: 398–401. doi:10.1097/ICU.0b013e3282be8fbb BernardiniFP BazzanM Lymphoproliferative disease of the orbit Curr Opin Ophthalmol 2007 18 398 401 10.1097/ICU.0b013e3282be8fbb Open DOISearch in Google Scholar

11. Khan SN, Sepahdari AR. Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies. Saudi J Ophthalmol 2012; 26: 373–83. doi: 10.1016/j.sjopt.2012.08.001 KhanSN SepahdariAR Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies Saudi J Ophthalmol 2012 26 373 83 10.1016/j.sjopt.2012.08.001 Open DOISearch in Google Scholar

12. Sullivan TJ, Valenzuela AA. Imaging features of ocular adnexal lymphoproliferative disease. Eye 2006; 20: 1189–95. doi: 10.1038/sj.eye.6702382 SullivanTJ ValenzuelaAA Imaging features of ocular adnexal lymphoproliferative disease Eye 2006 20 1189 95 10.1038/sj.eye.6702382 Open DOISearch in Google Scholar

13. Hui K-H, Pfeiffer ML, Esmaeli B. Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors. Saudi J Ophthalmol 2012; 26: 365–71. doi: 10.1016/j.sjopt.2012.08.008 HuiK-H PfeifferML EsmaeliB Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors Saudi J Ophthalmol 2012 26 365 71 10.1016/j.sjopt.2012.08.008 Open DOISearch in Google Scholar

14. J R, VA W, JM C, RD G. Lymphoproliferative, leukemic, and histiocytic lesions of the orbit. In: Rootman J, editor. Diseases of the orbit: a multidisciplinary approach. 2nd Edition. Philadelphia, USA: Lippincott Williams & Wilkins; 2003; p. 385–416. JR VAW JMC RDG Lymphoproliferative, leukemic, and histiocytic lesions of the orbit In: RootmanJ editor. Diseases of the orbit: a multidisciplinary approach 2nd Edition Philadelphia, USA Lippincott Williams & Wilkins 2003 385 416 Search in Google Scholar

15. Cohen V. Treatment options for ocular adnexal lymphoma (OAL). Clin Ophthalmol 2009; 3: 689–92. doi: 10.2147/OPTH.S5828 CohenV Treatment options for ocular adnexal lymphoma (OAL) Clin Ophthalmol 2009 3 689 92 10.2147/OPTH.S5828 Open DOISearch in Google Scholar

16. Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LLL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 2006; 108: 1451–60. doi:10.1182/blood-2006-02-005017 DecaudinD de CremouxP Vincent-SalomonA DendaleR RouicLLL Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options Blood 2006 108 1451 60 10.1182/blood-2006-02-005017 Open DOISearch in Google Scholar

17. Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020; 31: 17–29. doi: 10.1016/j.annonc.2019.10.010 ZuccaE ArcainiL BuskeC JohnsonPW PonzoniM RadererM Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2020 31 17 29 10.1016/j.annonc.2019.10.010 Open DOISearch in Google Scholar

18. Graue GF, Finger PT, Maher E, Della Rocca D, Della Rocca R, Lelli GJ Jr, et al. Ocular Adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Eur J Ophthalmol 2013; 23: 344–55. doi: 10.5301/ejo.5000224 GraueGF FingerPT MaherE Della RoccaD Della RoccaR LelliGJJr Ocular Adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor Eur J Ophthalmol 2013 23 344 55 10.5301/ejo.5000224 Open DOISearch in Google Scholar

19. Jezeršek Novaković B. [Recommendations for the management of patients with malignant lymphomas]. [Slovenian]. 2023. Ljubljana: Institute of Oncology Ljubljana. [internet]. [cited 2024 Mar 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/smernice/Priporocila_za_obravnavo_bolnikov_z_malignimi_limfomi_2023.pdf. Published 2023. Jezeršek NovakovićB [Recommendations for the management of patients with malignant lymphomas]. [Slovenian] 2023 Ljubljana Institute of Oncology Ljubljana [internet]. [cited 2024 Mar 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/smernice/Priporocila_za_obravnavo_bolnikov_z_malignimi_limfomi_2023.pdf. Published 2023. Search in Google Scholar

20. Swerdlow S, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoetic and lmyphoid tissues. 4th edition. Lyon: IARC; 2017. SwerdlowS CampoE HarrisN JaffeES PileriSA SteinH editors WHO classification of tumours of haematopoetic and lmyphoid tissues 4th edition Lyon IARC 2017 Search in Google Scholar

21. Dalvin LA, Salomão DR, Patel SV. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota. Br J Ophthalmol 2018; 102: 1728–34. doi: 10.1136/bjophthalmol-2017-311530 DalvinLA SalomãoDR PatelSV Population-based incidence of conjunctival tumours in Olmsted County, Minnesota Br J Ophthalmol 2018 102 1728 34 10.1136/bjophthalmol-2017-311530 Open DOISearch in Google Scholar

22. Fernández C, Henry R, Shields C, Bilyk JR, Lally SE, Eagle RC, et al. Ocular adnexal lymphoma: a single-institution retrospective study. Saudi J Ophthalmol 2021; 35: 230–8. doi: 10.4103/1319-4534.343368 FernándezC HenryR ShieldsC BilykJR LallySE EagleRC Ocular adnexal lymphoma: a single-institution retrospective study Saudi J Ophthalmol 2021 35 230 8 10.4103/1319-4534.343368 Open DOISearch in Google Scholar

23. Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 2007; 31: 170–84. doi: 10.1097/01.pas.0000213350.49767.46 FerryJA FungCY ZukerbergL Lymphoma of the ocular adnexa: a study of 353 cases Am J Surg Pathol 2007 31 170 84 10.1097/01.pas.0000213350.49767.46 Open DOISearch in Google Scholar

24. Tanenbaum RE, Galor A, Dubovy SR, Karp CL. Classification, diagnosis, and management of conjunctival lymphoma. Eye Vis 2019; 6: 22. doi: 10.1186/s40662-019-0146-1 TanenbaumRE GalorA DubovySR KarpCL Classification, diagnosis, and management of conjunctival lymphoma Eye Vis 2019 6 22 10.1186/s40662-019-0146-1 Open DOISearch in Google Scholar

25. Yen MT, Bilyk JR, Wladis EJ, Bradley EA, Mawn LA. Treatments for ocular adnexal lymphoma. Ophthalmology 2018; 125: 127–36. doi: 10.1016/j.ophtha.2017.05.037 YenMT BilykJR WladisEJ BradleyEA MawnLA Treatments for ocular adnexal lymphoma Ophthalmology 2018 125 127 36 10.1016/j.ophtha.2017.05.037 Open DOISearch in Google Scholar

26. Rasmussen P, Sjo LD, Prause JU, Ralfkiaer E, Heegaard S. Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol 2009; 93: 1047–51. doi: 10.1136/bjo.2008.146910 RasmussenP SjoLD PrauseJU RalfkiaerE HeegaardS Mantle cell lymphoma in the orbital and adnexal region Br J Ophthalmol 2009 93 1047 51 10.1136/bjo.2008.146910 Open DOISearch in Google Scholar

27. Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol 2019; 64: 45–66. doi: 10.1016/j.survophthal.2018.08.002 OlsenTG HeegaardS Orbital lymphoma Surv Ophthalmol 2019 64 45 66 10.1016/j.survophthal.2018.08.002 Open DOISearch in Google Scholar

28. Meunier J, Rouïc LL-L, Dendale R, Vincent-Salomon A, Asselain B, Arnaud P, et al. Conjunctival low-grade non-Hodgkin’s lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors. Leuk Lymphoma 2006; 47: 1295–305. doi: 10.1080/10428190500518966 MeunierJ RouïcLL-L DendaleR Vincent-SalomonA AsselainB ArnaudP Conjunctival low-grade non-Hodgkin’s lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors Leuk Lymphoma 2006 47 1295 305 10.1080/10428190500518966 Open DOISearch in Google Scholar

29. White WL, Ferry JA, Harris NL, Grove AS. Ocular adnexal lymphoma. Ophthalmology 1995; 102: 1994–2006. doi: 10.1016/S0161-6420(95)30764-6 WhiteWL FerryJA HarrisNL GroveAS Ocular adnexal lymphoma Ophthalmology 1995 102 1994 2006 10.1016/S0161-6420(95)30764-6 Open DOISearch in Google Scholar

30. Knowles DM, Jakobiec FA, Mcnally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990; 21: 959–73. doi: 10.1016/0046-8177(90)90181-4 KnowlesDM JakobiecFA McnallyL BurkeJS Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987 Hum Pathol 1990 21 959 73 10.1016/0046-8177(90)90181-4 Open DOISearch in Google Scholar

31. Andrew NH, Coupland SE, Pirbhai A, Selva D. Lymphoid hyperplasia of the orbit and ocular adnexa: a clinical pathologic review. Surv Ophthalmol 2016; 61: 778–90. doi: 10.1016/j.survophthal.2016.04.004 AndrewNH CouplandSE PirbhaiA SelvaD Lymphoid hyperplasia of the orbit and ocular adnexa: a clinical pathologic review Surv Ophthalmol 2016 61 778 90 10.1016/j.survophthal.2016.04.004 Open DOISearch in Google Scholar

32. Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011; 100: 86–92. doi: 10.1016/j.radonc.2011.05.013 LowryL SmithP QianW FalkS BensteadK IllidgeT Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial Radiother Oncol 2011 100 86 92 10.1016/j.radonc.2011.05.013 Open DOISearch in Google Scholar

33. De Castro B, Peixeiro RP, Mariz JM, Oliveira Â. Ultra-low dose radiotherapy in the management of low-grade orbital lymphomas. Reports Pract Oncol Radiother 2022; 27: 467–73. doi: 10.5603/RPOR.a2022.0044 De CastroB PeixeiroRP MarizJM Oliveira Ultra-low dose radiotherapy in the management of low-grade orbital lymphomas Reports Pract Oncol Radiother 2022 27 467 73 10.5603/RPOR.a2022.0044 Open DOISearch in Google Scholar

34. Park J, Yea JW, Oh SA, Kim MK, Son JH, Park JW. Prospective study of 4 Gy radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma (FORMAL). Cancers 2022; 14: 4274. doi: 10.3390/cancers14174274 ParkJ YeaJW OhSA KimMK SonJH ParkJW Prospective study of 4 Gy radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma (FORMAL) Cancers 2022 14 4274 10.3390/cancers14174274 Open DOISearch in Google Scholar

35. Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, et al. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 2006; 17: 135–40. doi: 10.1093/annonc/mdj025 TanimotoK KanekoA SuzukiS SekiguchiN MaruyamaD KimSW Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma Ann Oncol 2006 17 135 40 10.1093/annonc/mdj025 Open DOISearch in Google Scholar

36. Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26: 116–25. doi: 10.1093/annonc/mdv304 TillyH Gomes da SilvaM VitoloU JackA MeignanM Lopez-GuillermoA Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2015 26 116 25 10.1093/annonc/mdv304 Open DOISearch in Google Scholar

37. Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28(Suppl 4): iv62–71. doi: 10.1093/annonc/mdx223 DreylingM CampoE HermineO JerkemanM Le GouillS RuleS Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2017 28 Suppl 4 iv62 71 10.1093/annonc/mdx223 Open DOISearch in Google Scholar

38. Portell CA, Aronow ME, Rybicki LA, Macklis R, Singh AD, Sweetenham JW. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone sub-type. Clin Lymphoma Myeloma Leuk 2014; 14: 203–10. doi: 10.1016/j.clml.2013.10.011 PortellCA AronowME RybickiLA MacklisR SinghAD SweetenhamJW Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone sub-type Clin Lymphoma Myeloma Leuk 2014 14 203 10 10.1016/j.clml.2013.10.011 Open DOISearch in Google Scholar